Search research articles
Contact Us
Filters
Showing results (31-40 of 34) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 34 results.
Blood Reviews
|
September 30, 2025
Management of relapsed refractory multiple myeloma: Evidence-based guide to community oncologists
Ali Mushtaq, Asfand Yar Cheema, Hossam M Ali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 14, 2023
Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Eileen M Boyle, Patrick Blaney, James H Stoeckle, et al.
Blood
|
May 7, 2025
A multiomic analysis of Waldenström macroglobulinemia defines distinct disease subtypes
Dylan C Gagler, Hussein Ghamlouch, Di Zhang, et al.
Transplantation and Cellular Therapy
|
June 4, 2024
Absolute Lymphocyte Count and Outcomes of Multiple Myeloma Patients Treated with Idecabtagene Vicleucel: The US Myeloma Immunotherapy Consortium Real- World Experience
Jack Khouri, Danai Dima, Hong Li, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 34) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 34 results.
Blood Reviews
|
September 30, 2025
Management of relapsed refractory multiple myeloma: Evidence-based guide to community oncologists
Ali Mushtaq, Asfand Yar Cheema, Hossam M Ali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 14, 2023
Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
Eileen M Boyle, Patrick Blaney, James H Stoeckle, et al.
Blood
|
May 7, 2025
A multiomic analysis of Waldenström macroglobulinemia defines distinct disease subtypes
Dylan C Gagler, Hussein Ghamlouch, Di Zhang, et al.
Transplantation and Cellular Therapy
|
June 4, 2024
Absolute Lymphocyte Count and Outcomes of Multiple Myeloma Patients Treated with Idecabtagene Vicleucel: The US Myeloma Immunotherapy Consortium Real- World Experience
Jack Khouri, Danai Dima, Hong Li, et al.
Page
of 4